Search

The Role of Cetuximab and Other Epidermal Growth Factor Receptor Monoclonal Antibodies in the Treatment of Advanced Non-Small Cell Lung Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 3 Issue: 3 Year: 2008 Page: 217-227
Author(s): Antonio Rossi, Emilio Bria, Paolo Maione, Giovanni Palazzolo, Marzia Falanga, Cesare Gridelli

Targeted Therapies in Head and Neck Cancer: Past, Present and Future

Journal: Reviews on Recent Clinical Trials
Volume: 3 Issue: 3 Year: 2008 Page: 156-166
Author(s): Alexander D. Rapidis, Jan B. Vermorken, Jean Bourhis

Current Adjuvant and Targeted Therapies for Pancreatic Adenocarcinoma

Journal: Current Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2008 Page: 1674-1683
Author(s): Sabrina E. Sanchez, Jose G. Trevino

Monoclonal Antibodies as Innovative Therapeutics

Journal: Current Pharmaceutical Biotechnology
Volume: 9 Issue: 6 Year: 2008 Page: 423-430
Author(s): Janice M. Reichert

Cetuximab: Its Use in Combination with Radiation Therapy and Chemotherapy in the Multimodality Treatment of Head and Neck Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 3 Issue: 2 Year: 2008 Page: 76-83
Author(s): Timothy D. Wagner, Gary Y. Yang

Journal: Current Cancer Drug Targets
Volume: 8 Issue: 5 Year: 2008 Page: 431-445
Author(s): K. Agelopoulos, H. Buerger, B. Brandt

Trends in the Exploration of Anticancer Targets and Strategies in Enhancing the Efficacy of Drug Targeting

Journal: Current Molecular Pharmacology
Volume: 1 Issue: 3 Year: 2008 Page: 213-232
Author(s): F. Zhu, C. J. Zheng, L. Y. Han, B. Xie, J. Jia, X. Liu, M. T. Tammi, S. Y. Yang, Y. Q. Wei, Y. Z. Chen